Clinical Trial Update: Overactive Bladder Syndrome: Incobotulinumtoxin Versus Onabotulinumtoxin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing incobotulinumtoxin to onabotulinumtoxin for overactive bladder syndrome; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder Syndrome

Drugs mentioned

• incobotulinumtoxin (incobotulinumtoxin)
• onabotulinumtoxin (onabotulinumtoxin)

Snippet

Sponsor: University Of Perugia | Conditions: Overactive Bladder Syndrome | Phase 3 | Status: UNKNOWN